RSS   Newsletter   Contact   Advertise with us
Post Online Media

Arix Bioscience appoints Giles Kerr to board

Giles KerrArix Bioscience, a healthcare and life science company, announces the appointment of Giles Kerr as a non-executive director and chairman of the board's audit committee.

Mr. Kerr has 36 years' experience in finance across a broad range of industrial sectors with a particular focus on life sciences.

Mr. Kerr is currently the Director of Finance at the University of Oxford, and during his tenure he has established a successful investment office.

He is also a Director of Oxford University Innovation Ltd, Adaptimmune Therapeutics plc, BTG plc, Senior plc and PayPoint plc.

Mr. Kerr was previously the Chief Financial Officer of Amersham plc, acquired by GE Healthcare in 2004, and prior to that he was a partner with Arthur Andersen in the UK.

Mr. Kerr is a Fellow of Keble College, Oxford, a graduate of the University of York and a Fellow of the Institute of Chartered Accountants in England and Wales.


 LATEST MOVES FROM United Kingdom 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy